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Abstract 
Background: Despite the implementation of vector control strategies, including insecticide-treated bed nets (ITN) 
and indoor residual spraying (IRS) in western Kenya, this area still experiences high level of malaria transmission. Novel 
vector control tools are required which target such vector species, such as Anopheles arabiensis, that feed outdoors 
and have minimal contact with ITNs and IRS.
Methods: To address this need, ivermectin, eprinomectin, and fipronil were evaluated in Zebu cattle under semi-field 
conditions to evaluate the potential of these compounds to reduce the survival of blood feeding An. arabiensis. Over 
the course of four experiments, lactating cattle received doses of oral ivermectin at 0.1 or 0.2 mg/kg, oral eprinomec-
tin at 0.2 or 0.5 mg/kg, topical eprinomectin at 0.5, 0.75, or 1.5 mg/kg, or oral fipronil at 0.25, 0.5, 1.0, or 1.5 mg/kg. On 
days 1, 3, 5, 7, 14, and 21 days post-treatment, cattle were exposed to An. arabiensis, and mosquito mortality post-
blood feeding was monitored. For the analysis of survival data, the Kaplan–Meier estimator and Mantel–Haenszel test 
was used to contrast the treatment and control survival functions.
Results: All three compounds significantly reduced the survival time of An. arabiensis. Twenty-one days post-
treatment, mortality of mosquitoes fed on cattle dosed orally with 0.2 or 0.5 mg/kg eprinomectin, topically with 
eprinomectin at 0.5 mg/kg, or orally with either 1.0 or 1.5 mg/kg fipronil was still significantly higher than control 
mortality.
Conclusions: These data demonstrate the effectiveness of three insecticidal compounds administered systemically 
to cattle for controlling the cattle-feeding mosquito An. arabiensis. Eprinomectin and fipronil provided the longest-
lasting control. Such endectocidal treatments in cattle are a promising new strategy for control of residual, outdoor 
malaria transmission and could effectively augment current interventions which target more endophilic vector 
species.
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Background
While great strides are being made towards reducing the 
worldwide malaria burden, malaria still caused an esti-
mated 584,000 deaths in 2013, mostly among African 
children [1]. In Kenya, there are an estimated 6.7 million 
new clinical cases and 4000 deaths each year, and those 
living in western Kenya have an especially high risk of 
malaria [2]. Malaria prevalence is highest in Kenya in the 
lake endemic zone (38  %), is caused primarily by Plas-
modium falciparum [3], and remains the most common 
cause of child morbidity in western Kenya [4]. In this 
region, P. falciparum is vectored by Anopheles gambiae 
sensu stricto (s.s.), An. arabiensis, and Anopheles funes-
tus s.s. [5]. Given the behavioural diversity among these 
three vector species, a strategic investment must be made 
towards understanding their ecologies in order to design 
an effective, integrated management approach [6].
Anopheles gambiae s.s. and An. funestus s.s. are both 
highly anthropophilic, but An. arabiensis feeds readily 
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on non-human vertebrates, particularly cattle [7–9]. 
Anthropophily in An. arabiensis also varies significantly, 
ranging from a high preference for human blood in West 
Africa to almost exclusive zoophily in Madagascar [7, 10–
12]. In western Kenya, over half of the blood meals iden-
tified from An. arabiensis came from cattle, but a small 
proportion of An. gambiae s.s. also fed on cattle [13]. 
In areas where An. arabiensis is more anthropophagic, 
blood feeding still occurs predominately outdoors [14]. 
These behaviour traits make An. arabiensis less likely to 
encounter control strategies, which target endophagic 
and endophilic mosquitoes.
Zhou et  al. [15] documented a resurgence of malaria 
parasite prevalence and malaria vectors in western Kenya 
despite increased usage of ITNs, which could be attrib-
uted to insecticide resistance and poor ITN coverage or 
usage. However, over the last 10  years, An. gambiae s.s. 
and An. arabiensis have also undergone changes in their 
relative abundance, likely influenced by the implementa-
tion of IRS and ITNs [13, 16]. While these strategies have 
led to the reduction of An. gambiae s.s. and An. funestus 
s.s., an unintentional consequence has been a proportion-
ate increase in An. arabiensis [13]. Therefore, novel con-
trol strategies are needed for use in integrated malaria 
management programmes that target outdoor-feeding 
vectors not effectively controlled by ITNs and IRS.
One such approach is the use of “endectocides”, or 
treatment of a vertebrate host with a systemic insecticide 
that haematophagous arthropod vectors would become 
exposed to upon blood feeding. This host-targeted insec-
ticide strategy for vector control has already been dem-
onstrated effective in reducing sand fly vectors of visceral 
and cutaneous leishmaniasis [17–20], and flea vectors of 
plague [21, 22]. Targeting cattle, a frequent blood host of 
An. arabiensis [7–9, 12, 13], with a systemic insecticide 
may be an efficient approach to control this vector spe-
cies. Foy et al. [23] discussed the application and poten-
tial impact of ivermectin and other endectocides on 
malaria control. Community-directed ivermectin treat-
ment of humans is already main strategy for control of 
onchocerciasis [24], and has been successfully used in 
humans for malaria control as well [23, 25]. Many stud-
ies have demonstrated the lethal effect of ivermectin on 
mosquitoes after imbibing ivermectin-treated blood 
[26–30]. Eprinomectin is commercially used for control 
of endoparasites of livestock [31] and was demonstrated 
to be as effective as ivermectin at killing blood-feeding 
An. gambiae s.s. in the laboratory [30]. However, further 
investigation is needed to determine whether efficacy 
against mosquitoes is maintained in an in  vivo system, 
and ascertain the duration of effectiveness. Fipronil is a 
broad spectrum insecticide which blocks the GABA-
gated ion channels in the central nervous system [32]. 
Fipronil has been used to control ectoparasites on 
domestic animals [33], and as a pour-on or dip for cattle 
to control ticks [34, 35]. Mosquitoes are highly suscepti-
ble to fipronil during all life stages and by different routes 
of exposure [36–40]. However, field tests of fipronil as a 
systemic insecticide for mosquito control are currently 
lacking.
The long-term goal of the research is to create a prod-
uct that can be utilized in an integrated malaria man-
agement programme, particularly to augment current 
control methodologies aimed at endophilic vectors by 
targeting more exophilic vectors with broader host uti-
lization, such as An. arabiensis. To that end, this study 
examined the efficacy of ivermectin, eprinomectin and 
fipronil on the survivorship of adult An. arabiensis. The 
specific aim of this study was to determine the percent 
mortality of adult female An. arabiensis fed on cattle 
treated with different doses of ivermectin, eprinomec-




The study site was located 10 km west of Kisumu in the 
village of Kisian, Kenya (latitude −0.073220° and longi-
tude 34.662974°).
Cattle breed selection and cattle maintenance
All animal activities were reviewed and approved by the 
Institutional Animal Care and Use committees at Gen-
esis Laboratories, Inc. and the Kenya Medical Research 
Institute (KEMRI). Lactating Zebu cattle (Bos indicus) 
were leased or purchased from markets or from private 
individuals. Cattle were transported to the study cat-
tle shed located on the grounds of US Centers for Dis-
ease Control and Prevention and the Kenya Medical 
Research Institute (KEMRI), Kisian, Kenya. Transpor-
tation permits were provided by the department of vet-
erinary services nearest to each purchase location. Test 
subjects were housed in individual stalls (1.5  ×  3  m) 
within a covered cattle shed and were allowed periodic 
grazing in an outdoor pen during the 12-days acclima-
tion period.
Upon arrival to the test facility each cow received an 
ear tag with a unique identification number and was 
inspected for general health. All test subjects were pro-
vided with clean tap water ad  libitum and clean feed 
consisting of 8 kg of chopped Napier grass (Pennisetum 
purpureum) and 1.3 kg of dairy meal per day as directed 
by project veterinarians.
Cattle (test subjects) were maintained in a semi-con-
trolled environment with adequate ventilation and natu-
ral light. Each test subject’s general health, and the daily 
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temperature and relative humidity of the animal facility 
were documented by staff during the acclimation period 
and the test.
Treatment randomization
A blocked randomization scheme by body weight was 
used to eliminate possible bias. Randomization was car-
ried out using a random number generator service [41]. 
Each of the test subjects was assigned to either a control or 
treatment group. For each experiment, treatment groups 
which received doses of insecticide (test substance) con-
sisted of three lactating Zebu cattle each, and the control 
group was allocated two lactating Zebu cattle. Precautions 
were taken to avoid animals contacting or grooming each 
other. The animals were housed individually in separate 
pens with a minimum distance to avoid contact between 
animals within and between treatment groups. Control 
animals were separated from the treatment animals.
Administration of the test substance
Four experiments were conducted in order to evalu-
ate multiple doses each of ivermectin, fipronil, and 
eprinomectin (Table  1). Experiment 1, conducted from 
20 Dec 2012–22 Jan 2013, consisted or dosing cattle 
orally with eprinomectin at doses of 0.2 or 0.5  mg/kg, 
or topically with 0.5  mg/kg eprinomectin (Eprinex®). 
In experiment 2, conducted between 23 Jan 2013–26 
Feb 2013, cattle were dosed orally with 0.1 or 0.2  mg/
kg ivermectin, or topically with 0.75  mg/kg eprinomec-
tin. In experiment 3, conducted from 25 Apr 2013–6 Jun 
2013, cattle were dosed orally with either 1.0 or 1.5 mg/
kg fipronil, or topically with 1.5  mg/kg eprinomectin. 
Experiment 4, conducted from 8 Aug 2013–22 Sept 2013, 
cattle received oral doses of fipronil at either 0.25 or 
0.5 mg/kg. For each of these experiments, cows were ran-
domized into 3 cows per treatment group and 2 cows per 
control for a total of 11 cows per experiment. Test sub-
stance quantity was calculated using weights recorded 
no more than 3  days prior to dosing. Topical and oral 
application methods of administering eprinomectin were 
chosen to assess efficacy and explore differences between 
application routes on mosquito survivorship.
Experiment 1 Cattle in treatment group one (T1) 
received an eprinomectin dose of 0.2 mg/kg orally, sub-
jects in T2 received 0.5 mg/kg orally and subjects in T3 
received 0.5 mg/kg topically. Because eprinomectin is not 
commercially available in oral formulations, crystalline 
eprinomectin was weighed in the laboratory and placed 
in a capsule for oral application. For T3, eprinomec-
tin was applied topically using liquid Eprinex© (Merial 
Ltd., New Zealand) which was applied according to the 
manufacturer’s application directions. The manufacturer 
recommended application for Eprinex© pour-on com-
mercial product is 1 ml/10 kg which would achieve a dos-
age of 0.5 mg eprinomectin/kg body weight.
Experiment 2 Treatment group T1 received a 0.1 mg/
kg ivermectin orally, subjects in T2 received 0.2  mg/kg 
ivermectin orally and subjects in T3 received 0.75  mg/
kg eprinomectin topically. Ivermectin was administered 
orally using boluses; ivermectin tablets were weighed 
in the laboratory and placed in a capsule for oral appli-
cation. Eprinomectin was applied topically using liquid 
Eprinex© applied according to the manufacturer’s appli-
cation directions, but with a higher dose.
Table 1 Listing of active ingredients, concentrations, route of administrations and total number of engorged mosquitoes 
used in the survival analysis per experiment
Experiment Treatment group Active ingredient Concentration Route of administration Mosquito sample size
1 T0 Control n/a n/a 379
T1 Eprinomectin 0.2 mg/kg Oral 465
T2 Eprinomectin 0.5 mg/kg Oral 396
T3 Eprinomectin 0.5 mg/kg Topical 408
2 T0 Control n/a n/a 511
T1 Ivermectin 0.1 mg/kg Oral 475
T2 Ivermectin 0.2 mg/kg Oral 416
T3 Eprinomectin 0.75 mg/kg Topical 522
3 T0 Control n/a n/a 522
T1 Eprinomectin 1.5 mg/kg Topical 537
T2 Fipronil 1.0 mg/kg Oral 599
T3 Fipronil 1.5 mg/kg Oral 575
4 T0 Control n/a n/a 460
T1 Fipronil 0.5 mg/kg Oral 429
T2 Fipronil 0.25 mg/kg Oral 407
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Experiment 3 Treatment group T1 received a 1.5 mg/kg 
eprinomectin topically, subjects in T2 received 1.0  mg/
kg fipronil orally and subjects in T3 received 1.5 mg/kg 
fipronil orally. Fipronil was administered orally using 
capsules. Technical grade fipronil was weighed in the 
laboratory and placed in a capsule for oral applica-
tion. Eprinomectin was applied topically using liquid 
Eprinex©, applied as described above, but with a higher 
dose.
Experiment 4 Treatment group T1 received a fipronil 
dose of 0.5  mg/kg orally while subjects in T2 received 
0.25  mg/kg orally. Fipronil was weighed in a laboratory 
and placed in a capsule for oral application. For each 
experiment, the control group (T0) was left untreated.
Animal subject performance
Clinical observations of test subjects were recorded daily 
by project staff during acclimation and experimentation 
phases of the study. In addition, a veterinarian conducted 
weekly health checks to more thoroughly examine test 
subject health. During application and experimentation 
periods, feed was weighed daily to assess the effects of 
test substances on the animals’ appetite. When spillage 
occurred, feed was returned to the appropriate container 
and weighed to the nearest 0.5 gram. Cattle weights 
were recorded on the final day of acclimation and weekly 
throughout the course of the study. Differences in appe-
tite and body mass were compared by evaluating test 
subject weight means and standard deviations before and 
after treatment.
Mosquito bioassays
All An. arabiensis used in this study were reared at the 
KEMRI/CDC, Kisian station, Kenya. Efficacy of each 
treatment was assessed by comparing survivorship of 
fully blood fed An. arabiensis at 1, 3, 5, 7, 14 and 21 days 
post treatment in experiments 1 and 2. While in experi-
ment 3 mosquitoes were exposed at days 1, 7, 10, 14 and 
21, in experiment 4 we exposed mosquitoes in days 1, 3, 
5, 7, 14 and 21.
Prior to bioassays approximately 600 An. arabien-
sis adults were separated into an experimental cage and 
starved for 12  h. The day of application, 11–12 plastic 
capsules were filled with approximately 50 3–4  day-old 
female mosquitoes. Containers were modified round 
paper cartons that were 9.5 cm deep and 8.5 cm in diam-
eter, covered with nylon netting material on one end to 
facilitate blood feeding. Containers with mosquitoes 
were transported in a cooler to and from the cattle shed.
The day before application all cows had a circular patch 
approximately 6 inches in diameter shaved on the ven-
tral portion of the abdomen to expose skin and facilitate 
feeding. One container with An. arabiensis was applied 
to the shaved location of each test subject and secured by 
wrapping an ace bandage around the torso. One test sub-
ject in the control group received one capsules to ensure 
that the number of cartons applied to each group was 
equal. Containers were attached to test subjects for 30 min, 
and then carefully removed, and blood-fed females were 
counted. Unfed females were removed from the study.
Data were only analyzed for fully-engorged female 
mosquitoes. Blood fed females were placed into cages, 
provided with a 10  % sugar source ad  libitum. For each 
group of mosquitoes in experiment 1 and 2, mortality 
was monitored at 3, 6 and 24  h post feeding and then 
daily for approximately 12 days thereafter. In experiment 
3 and 4 we followed the same scheme but mortality was 
recorded daily for 9 days after the first 24 h.
Statistical analysis
The statistical analysis of the survival data obtained from 
the control and treatment groups was conducted using 
the “survival” package [42] for the software R [43]. The 
package implements the Kaplan–Meier estimator, which 
is used to calculate the survival function of a random 
variable in time. A survival curve is the plot of the sur-
vival function representing the survivorship of the target 
population. The statistical difference between the control 
and the treatment was assessed using the Mantel–Haen-
szel test as implemented in the survival package. Val-
ues smaller than 0.05 represent a significant difference 
between the control and treatment group. The resulting 
survival functions were used to estimate the median sur-
vival time and 95 % confidence intervals for the estimate 
and the size of the effect of the active ingredient (Table 2).
To compare the effect of time on the effectiveness of 
the test substance we did a post hoc analysis for the same 
concentration and delivery method (a single row on a 
table). For this, the significant level was adjusted using 
a Bonferroni correction (α/n, where α is the significance 
level set at 0.05 and n is the number of comparisons).
Results
Cattle observations, health, and performance
No adverse health effects arose in association with the 
treatments. For experiments 1–3, the test subject’s mean 
daily feed consumption did not differ between the accli-
mation and test periods. For experiment 4, test subjects’ 
mean daily feed consumption increased slightly from the 
acclimation (µ = 7.5 kg of hay/day, σ = 0.37) to the test 
period (µ =  7.8  kg of hay/day, σ =  0.02); t (15) =  2.13, 
p = 0.049. None of the cattle in any of the experiments 
experienced any large changes in their body mass over 
the course of the study.
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Mosquito bioassays
The data are presented in table form, with survival curves 
for all treatment groups and time points available in addi-
tional file 1. Table 2 shows the median survival time (and 
95 % confidence intervals) with experiments separated by 
horizontal lines, each row correspond to a treatment (or 
control) in an experiment and each column is a time point 
when mosquitoes were challenged. Tables 3, 4, 5, 6 corre-
spond to an experiment and each row shows the result for 
the active ingredient, concentration and delivery method. 
The columns represent the day post-exposure when mos-
quitoes were challenged against the test substance. The 
values shown are the p value of the comparison between a 
particular treatment and the control at a given day. 
Experiment 1 Mortality of mosquitoes fed on cattle 
dosed orally with 0.2  mg/kg eprinomectin was delayed 
during the days immediately following treatment. Survi-
vorship of mosquitoes in this group was not significantly 
different from the controls until 5  days post-treatment, 
but then remained significant out to 21 days post-treat-
ment (Table 3) with the exception of day 7. In contrast, 
mortality of mosquitoes fed on cattle dosed orally or 
topically with 0.5  mg/kg eprinomectin was significantly 
different from controls by 1 day post-treatment (Table 3). 
The 7-day time point post-treatment was an anomaly, a 
control replicate had a large mortality by 24 h.
Experiment 2 At the lowest dose of ivermectin, 0.1 mg/
kg, mosquito survivorship was marginally significantly 
different from the control at 1  day post-treatment, but 
then not significant (Table 4). For mosquitoes fed on cat-
tle dosed with 0.2  mg/kg ivermectin, survivorship was 
significantly different from the controls at 1, 5 and 7, but 
not at 3, 14 and 21  days. For mosquitoes fed on cattle 
dosed topically with 0.75 mg/kg eprinomectin, survivor-
ship was significantly different from the controls from 1 
to 7 days, but not at 14 or 21 days (Table 4).
Experiment 3 For mosquitoes fed on cattle dosed topi-
cally with 1.5 mg/kg eprinomectin, survivorship was sig-
nificantly different from the control out to 10  days, but 
not at 14 or 21 days (Table 5). For both doses of fipronil, 
mosquito survivorship was significantly different from 
the control at all time points out to 21 days (Table 5).
Table 2 Median survival time and 95 % confidence interval per experiment
Values in square brackets represent the 95 % confidence intervals for the estimated median lethal time; n/a, time point not tested; n/a1, denotes estimate nor 
applicable because the survival function did not reach 0.5, therefore there is not a median value estimate; ∞, infinity, the survival function did not reach the 
corresponding to 95 % limit value
h hours, d days, Exp. experiment, OE oral eprinomectin, TE topical eprinomectin, OI oral ivermectin, OF oral fipronil
Hours/experiment 24 h (1 d) 72 h (3 d) 120 h (5 d) 168 h (7 d) 240 h (10 d) 336 h (14 d) 504 h (21 d)
Exp. 1 control 216 [168, 264] 144 [96, 192] 168 [144, 192] 96 [48, 216] n/a 156 [96, 192] 120 [96, 168]
0.2 mg/Kg OE 192 [144, 264] 72 [72, 96] 120 [96, 168] 192 [168, 192] n/a 24 [24, 96] 96 [96, 120]
0.5 mg/Kg OE 24 [24, 24] 48 [48, 72] 72 [72, 96] 168 [120, 216] n/a 24 [24, 72] 96 [96, 96]
0.5 mg/Kg TE 48 [48, 72] 72 [48, 72] 48 [48, 72] 72 [72, 96] n/a 48 [48, 72] 96 [96, 120]
Exp. 2 control 144 [120, 168] 72 [48, 120] 216 [168, 288] 240 [216, 264] n/a 192 [168, 192] 120 [120, 120]
0.1 mg/Kg OI 96 [72, 96] 48 [48, 72] 132 [48, 264] 144 [96, 240] n/a 192 [168, 216] 120 [120, 144]
0.2 mg/Kg OI 72 [72, 72] 60 [48, 72] 72 [72, 120] 144 [96, 168] n/a 168 [144, 216] 120 [120, 120]
0.75 mg/Kg TE 48 [48, 48] 48 [24, 48] 48 [48, 48] 48 [48, 72] n/a 168 [144, 192] 120 [120, 120]
Exp.3 control n/a1 [−∞, ∞] n/a n/a 216 [216, 240] 168 [144, 168] 192 [192, 240] n/a1 [240, ∞]
1.5 mg/Kg TE 24 [24, 24] n/a n/a 48 [24, 48] 72 [48, 96] 192 [192, 240] n/a1 [216, ∞]
1.0 mg/Kg OF 24 [24, 24] n/a n/a 48 [48, 48] 72 [72, 96] 132 [72, 192] 144 [72, 240]
1.5 mg/Kg OF 24 [24, 24] n/a n/a 24 [24, 48] 48 [24, 48] 84 [48, 144] 72 [48, 168]
Exp. 4 control 144 [120, 144] 168 [168, 216] n/a 192 [168, 240] n/a n/a1 [216, ∞] 240 [216, ∞]
0.25 mg/Kg OF 48 [48, 48] 120 [96, 144] n/a 48 [48, 48] n/a 204 [144, ∞] 216 [192, ∞]
0.5 mg/Kg OF 48 [48, 72] 120 [120, 144] n/a 144 [144, 168] n/a 216 [144, ∞] n/a1 [216, ∞]
Table 3 Kaplan-Meier curve comparisons (p values) for oral and topical doses of eprinomectin (experiment 1)
* Comparison statistically different from the control at an adjusted α of 0.003
Dose/days 1 3 5 7 14 21
0.2 mg/Kg oral 0.92 0.23 5.7 × 10−4* 0.11 3.26 × 10−4* 3.24 × 10−4*
0.5 mg/Kg oral 2.37 × 10−37* 3.74 × 10−4* 2.3 × 10−6* 0.12 0.09 4.43 × 10−4*
0.5 mg/Kg pour on 4.41 × 10−7* 8.82 × 10−6* 1.41 × 10−7* 0.148 0.001* 0.002*
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Experiment 4 For both doses of fipronil, mosquito sur-
vivorship was significantly different from the control out 
to 7  days (Table  6). Mosquito survivorship was not sig-
nificantly different from the control for either dose at 14 
and 21 days (Table 6).
Discussion
This study evaluated the endectocidal activity of three 
compounds in cattle against An. arabiensis mosquitoes in 
a semi-field environment. Positive results were achieved 
with each test substance, but with varying degrees of effi-
cacy depending on dose and route of administration.
Ivermectin
Ivermectin mass drug administration (MDA) to humans 
for onchocerciasis control has been demonstrated to also 
reduce malaria parasite transmission by affecting mos-
quito survivorship, vector competence, re-feeding rates, 
and parity [25, 29, 44, 45]. When administered to humans 
during MDA campaigns, the standard oral dose of iver-
mectin is 150  µg/kg. While the aforementioned studies 
and others have well-characterized the use of ivermectin 
as a human endectocide for malaria vector control, this 
study was one of the first to evaluate the use of ivermec-
tin in cattle for control of An. arabiensis.
Fritz et  al. [26] evaluated a commercially-available 
injectable formulation of ivermectin in cattle, and found 
that most (90  %) of the An. gambiae s.s. that fed on the 
ivermectin-treated cattle within two weeks of treatment 
failed to survive more than 10  days post-blood meal. 
Further, no eggs were deposited by An. gambiae s.s. that 
fed on ivermectin-treated cattle within 10  days of treat-
ment [26]. These results are promising, however inject-
able formulations are difficult to administer and require 
veterinary expertise. In that light, the current study 
evaluated two oral doses of ivermectin. Of these oral for-
mulations, the higher of the two doses (0.2  mg ivermec-
tin/kg) achieved significant results out to 7  days (168  h) 
post-treatment. This result is also consistent with the 
described pharmacokinetics of this compound. Ivermec-
tin has an elimination half-life of 32–178 h when admin-
istered intravenously, depending on species [46]. Day 3, 
in the ivermectin experiment, had a control replicate with 
large mortality (38  %) by 24  h. If the control replicate is 
removed, the median survival time in control is increased 
to 96 h; 95 % confidence interval [48, 120 h] (Table 2). The 
0.1  mg/Kg ivermectin treatment remains insignificant, 
while the 0.2 mg/Kg of ivermectin treatment becomes sig-
nificant (p = 0.001).
A significant effect on mosquito survivorship for 
approximately 1  week also corroborates the results 
obtained by Alout et  al. [25], whereby a 33.9  % reduc-
tion in survivorship of An. gambiae s.s. was observed for 
7 days following a MDA in humans. While this effect on 
mosquito survival was brief, a significant reduction in 
mosquito parity rates was observed for more than 2 weeks 
after the MDA [25]. Additionally, sporozoite rates were 
reduced by 77.5 % for 15 days [25]. Kobylinski et al. [45] 
similarly also observed a 79  % reduction in sporozoite-
positive An. gambiae s.s. for over 2 weeks following MDA. 
Therefore, ivermectin treatments in cattle may similarly 
impact the vectorial capacity of An. arabiensis in a field 
situation, and warrant further field investigation.
Table 4 Kaplan-Meier curve comparisons (p values) for oral doses of ivermectin and topical eprinomectin (experiment 2)
* Comparison statistically different from the control at an adjusted α of 0.003
Dose/days 1 3 5 7 14 21
0.1 mg/Kg iver. 0.0003* 0.098 0.199 0.017 0.082 0.568
0.2 mg/Kg iver. 4.4 × 10−16* 0.004 0.0006* 3.77 × 10−5* 0.244 0.903
0.75 mg/Kg eprino. 0.0* 3.1 × 10−11* 4.1 × 10−10* 0.0* 0.161 0.858
Table 5 Kaplan-Meier curve comparisons (p values) 
for oral doses of fipronil and topical eprinomectin (experi-
ment 3)
* Comparison statistically different from the control at an adjusted α of 0.003
Dose/days 1 7 10 14 21
1.5 mg/Kg 
eprino.
0.0* 0.0* 5.3 × 10−11* 0.734 0.351
1.0 mg/Kg 
fipro.
0.0* 0.0* 0.0* 0.006* 0.001*
1.5 mg/Kg 
fipro.
0.0* 0.0* 0.0* 8.32 × 10−11* 5.52 × 10−12*
Table 6 Kaplan-Meier curve comparisons (p values) 
for oral doses of fipronil (experiment 4)
* Comparison statistically different from the control at an adjusted α of 0.005
Dose/days 1 3 7 14 21
0.25 mg/Kg fipro. 0.0* 5.0 × 10−6* 5.5 × 10−14* 0.10 0.768
0.5 mg/Kg fipro. 0.0* 5.7 × 10−8* 6.8 × 10−5* 0.10 0.171
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Eprinomectin
Eprinomectin has established utility in the agricultural 
industry as an effective means to control endoparasite 
loads in cattle [31], with the additional health benefits 
of increasing cattle weight gain and milk production [31, 
47]. However, eprinomectin has not been widely used 
for public health purposes. Butters et  al. [30] evaluated 
eprinomectin alongside several other active ingredi-
ents in the laboratory for control of An. gambiae s.s. and 
found it had a similar LC50 to ivermectin. Fritz et al. [48] 
also evaluated eprinomectin and ivermectin in the labo-
ratory against An. arabiensis and found both compounds 
to be effective at killing mosquitoes at concentrations 
under 10 parts per billion. However, no studies to date 
have evaluated eprinomectin under field conditions for 
control of anopheline malaria vectors.
In this study two oral (0.2 and 0.5 mg/kg) and three top-
ical (0.5, 0.75, and 1.5 mg/kg) doses of eprinomectin were 
evaluated. Of the oral formulations, the lower dose dem-
onstrated a delayed effectiveness, with a significant effect 
on mosquito mortality at time points from 5 to 21 days 
post-treatment, but not at 7 days. In contrast, the 0.5 mg/
kg dose had a significant effect on mosquito mortality up 
to 5 days post-treatment and again at 21 days, but not at 
7 or 14 days. Of the topical (pour-on) formulations, sig-
nificant effects were observed immediately for all three 
doses (1  day post-treatment) (Tables  3, 4, 5), however, 
the lowest treatment (0.5  mg/kg) resulted in significant 
mosquito mortality for 21 days with the exception of day 
7 (Table  3), however as previously mentioned, day 7 of 
experiment 1 had large mortality in a control replicate 
(12/17 dead by 24  h). Removing this replicate increases 
the median survival time in the control from 96 h (95 % 
confidence interval 48, 116 h) to 192 h (95 % confidence 
interval 120, 264  h). As a result the topical 0.5  mg/kg 
eprinomectin treatment becomes statistically significant 
(p = 5.9 × 10−4).
For reasons unclear, the eprinomectin higher doses 
were effective for shorter periods of time (7  days for 
0.75 mg/kg for and 10 days for 1.5 mg/kg) than the lower 
doses (21  days for 0.5 and 0.2  mg/Kg). The long-lasting 
low-dose effect of eprinomectin are unexpected and 
despite a large sample size (Table  1) and low variability 
(Table  2) further experimentation will be necessary to 
confirm these results. Oral formulations of eprinomectin 
are currently not commercially available, but should be 
further developed for study due to the potential for low 
concentrations to have a significant killing effect on mos-
quitoes (Table 3).
The same dose and route of administration was 
assessed for eprinomectin and ivermectin, although in 
separate experiments. When comparing 0.2  mg/kg oral 
ivermectin (Table  4) and 0.2  mg/kg oral eprinomectin 
(Table 3), ivermectin was immediately effective with sig-
nificant mosquito mortality out to 7 days post-treatment, 
whereas the effectiveness of eprinomectin was delayed, 
but lasted out to 21 days. Laboratory studies comparing 
eprinomectin and ivermectin have also demonstrated 
comparable effectiveness of both compounds but with 
slightly different pharmacokinetics. Butters et  al. [30] 
reported significant knockdown of An. gambiae s.s. with 
both ivermectin and eprinomectin, however, the knock-
down effect of eprinomectin was within the first hour 
following the blood meal whereas the knockdown effect 
for ivermectin was not apparent until 24 h after the blood 
meal [30]. The discrepancy between our results and those 
of Butters et al. [30] may relate to the difference in phar-
macokinetics of these compounds under laboratory and 
in  vivo conditions. In the laboratory where mosquitoes 
were exposed to blood spiked with the active ingredient, 
the results obtained would related directly to the activity 
of the compound itself in the absence of any metabolites 
or conditions associated with feeding on treated cattle. 
Ivermectin and eprinomectin have similar plasma kinet-
ics and mean residence time (the amount of time one 
molecular stays in the organism) when administered to 
mice intravenously and orally, however with some varia-
tion in the rate and mechanism of drug elimination [49]. 
With the information available, it is also difficult to com-
pare the concentration of active ingredient mosquitoes 
would have been exposed to at corresponding time points 
between these publications, or to know the relative con-
tribution made by mosquito genetics, since Butters et al. 
[30] utilized An. gambiae s.s. G3 strain, and this study 
used An. arabiensis sourced in Kenya. Further study is 
warranted to ascertain the nature of the delayed knock-
down effect observed in An. arabiensis when exposed to 
eprinomectin circulating in cattle treated orally. More 
work is also needed to assess the complementary uses of 
these compounds in the field. Since eprinomectin is not 
approved for human use as is the case ivermectin, endec-
tocidal treatments in cattle with eprinomectin may be 
a complementary approach to the use of ivermectin in 
people when both An. gambiae s.s. and An. arabiensis are 
present.
Fipronil
Cattle were dosed orally with four different doses of 
fipronil over the course of two experiments. Fipronil 
dosing significantly reduced mosquito survivorship for 
at least 21  days when cattle were administered either 
1.0 or 1.5  mg/kg, and for at least 7  days at the lower 
doses of 0.25 and 0.5  mg/kg. A significant effect may 
have occurred at the 14-day time point for the 0.25 and 
0.5 mg/kg concentrations; however these data could not 
be analysed due to unexplained mortality in the control 
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groups. Poché et al. [19] also tested fipronil as an endec-
tocide in cattle, although for control of sand fly vectors 
of visceral leishmaniasis in India. In that study, four oral 
dose levels were evaluated: 0.5, 1.0, 2.0, and 4.0  mg/kg. 
Between 20  % (0.5  mg/kg) and 100  % (4.0  mg/kg) mor-
tality was observed in adult Phlebotomus argentipes sand 
flies fed on treated cattle 21  days post-treatment with 
fipronil [19]. At the 1.0  mg/kg dose level in both stud-
ies, control of adult sand flies [19] and mosquitoes (this 
study) was significantly different from the controls at 
21 days post treatment. This long-lasting efficacy makes 
fipronil a strong candidate for future malaria control field 
studies.
The use of fipronil as a public health endectocide has 
already been extensively evaluated for control of adult 
and larval sand fly vectors of leishmaniasis. In India, 
fipronil treatment of two rodent species resulted in 100 % 
mortality of P. argentipes larvae following consumption 
of treated feces [18]. In that same study, 100  % mortal-
ity of blood-feeding adult P. argentipes was also achieved 
when sand flies were allowed to feed on rodents up to 
20  days post-treatment [18]. In Tunisia, Derbali et  al. 
[20] reported that fipronil – treated baits consumed by 
the desert’s jird (Meriones shawi) had a systemic effect 
on the survival of Phlebotomus papatasi after blood meal 
acquisition, as well as a feed-through effect on the sur-
vival of larval P. papatasi after consumption of feces. And 
as mentioned above, treatment of cattle with fipronil also 
successfully controlled adult and larval P. argentipes for 
21 days [19]. Lopes et al. [35] also used fipronil treatment 
of cattle to control ivermectin-resistant cattle ticks, Rhi-
picephalus (Boophilus) microplus. The topically admin-
istered fipronil formulation (1  mg/kg) achieved efficacy 
values greater than 95  % from 3 to 28  days after treat-
ment. On 35, 42 and 49  days post-treatment, efficacy 
values were 94, 78 and 61 %, respectively [35]. The appli-
cation of fipronil as a cattle endectocide for malaria con-
trol is a natural extension of these studies.
Conclusions
Ivermectin, eprinomectin, and fipronil each show prom-
ising potential as endectocides administered to cattle for 
lowering the survival rate of An. arabiensis mosquitoes, 
and hence reducing malaria transmission rates. Mosquito 
mortality was significantly higher than control mortality 
as long as 21  days post-treatment after mosquitoes fed 
on cattle dosed orally with 0.2 or 0.5 mg/kg eprinomec-
tin, topically with eprinomectin at 0.5  mg/kg, or orally 
with either 1.0 or 1.5 mg/kg fipronil. Other components 
of vectorial capacity were not evaluated, and would be 
valuable to incorporate into future studies. Endectocidal 
treatments in cattle are a promising new strategy for con-
trol of residual, outdoor malaria transmission driven by 
vectors that feed on cattle, and could effectively augment 
current interventions which target more endophilic vec-
tor species.
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